SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001943462-24-000001
Filing Date
2024-02-14
Accepted
2024-02-14 10:09:20
Documents
1

Document Format Files

Seq Description Document Type Size
1 cycc_13gv3.htm SC 13G/A 81391
  Complete submission text file 0001943462-24-000001.txt   83109
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Subject) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-80136 | Film No.: 24633502
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 283 GREENWICH AVENUE 3RD FLOOR GREEWICH CT 06830
Business Address 283 GREENWICH AVENUE 3RD FLOOR GREEWICH CT 06830 203-632-6341
Dellora Investments LP (Filed by) CIK: 0001943462 (see all company filings)

IRS No.: 850748545 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A